US Patent Issued to ENDEAVOR HEALTH CLINICAL OPERATIONS, MULTIVIR on Aug. 18 for "Methods and compositions comprising enhanced targeted immune gene therapy for the treatment of cancer" (Illinois, Texas Inventors)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,708,653, issued on Aug. 18, was assigned to ENDEAVOR HEALTH CLINICAL OPERATIONS (Evanston, Ill.) and MULTIVIR INC. (Houston).

"Methods and compositions comprising enhanced targeted immune gene therapy for the treatment of cancer" was invented by Prem Seth (Evanston, Ill.), Sunil Chada (Houston), Dora Wiederhold (Houston), Kerstin B. Menander (Houston) and Robert E. Sobol (Houston).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are methods and compositions for treating cancer in an individual comprising administering to the individual an effective amount of an adenoviral vector with a genetically modified fiber incorporating a Lyp-1 peptid...